A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Name: A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-03-06 收录

下载链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2040375

下载链接

链接失效反馈

官方服务：

资源简介：

This study will assess the safety of RAD001 when given together with cetuximab and irinotecan

创建时间：

2007-05-15